Autoimmune Hepatitis: A Review of Current Diagnosis and Treatment
Author Information
Author(s): Ashima Makol, Kymberly D. Watt, Vaidehi R. Chowdhary
Primary Institution: Mayo Clinic College of Medicine
Hypothesis
An environmental agent is hypothesized to trigger an immune-mediated attack directed against liver antigens in genetically predisposed individuals.
Conclusion
Autoimmune hepatitis has an excellent long-term prognosis with early and aggressive treatment.
Supporting Evidence
- Autoimmune hepatitis is characterized by elevated immunoglobulins and autoantibodies.
- Early treatment with corticosteroids is crucial for a good prognosis.
- Long-term survival rates for treated patients are comparable to the general population.
Takeaway
Autoimmune hepatitis is a liver disease where the body's immune system attacks the liver, but with the right treatment, people can live a long and healthy life.
Methodology
The paper reviews the clinical presentation, risk factors, immunopathogenesis, diagnostic criteria, and treatment options for autoimmune hepatitis.
Limitations
The study does not provide specific data on treatment outcomes or long-term follow-up of patients.
Participant Demographics
The disease is more common in young women, but can affect individuals of all ages and ethnicities.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website